---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-020057"
form_type: "8-K"
ticker: "INTS"
cik: "0001567264"
company_name: "INTENSITY THERAPEUTICS, INC."
filed_at: "2025-04-25T23:59:59+00:00"
generated_at: "2026-05-23T05:51:04.907735+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Intensity Therapeutics prices $2.35M public offering of common stock and warrants

## Summary
- 3,133,333 shares and two series of warrants priced at $0.75 per unit; gross proceeds ~$2.35M.
- Net proceeds of ~$1.9M after 7% placement agent fee and expenses.
- Series B-1 warrants ($0.85 exercise, 5-yr term) and B-2 warrants ($0.85, 18-mo term).
- Proceeds for INVINCIBLE-4 patient enrollment, INVINCIBLE-3 treatment, and working capital.
- Offering expected to close April 28, 2025; A.G.P. and Brookline Capital Markets as placement agents.

## SEC filing metadata
- accession: 0001628280-25-020057
- form_type: 8-K
- ticker: INTS
- cik: 0001567264
- company_name: INTENSITY THERAPEUTICS, INC.
- filed_at: 2025-04-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1567264/000162828025020057/0001628280-25-020057-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1567264/000162828025020057/intensity-20250424.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-020057
- JSON: https://secwatch.observer/filing/0001628280-25-020057.json
- Plain text: https://secwatch.observer/filing/0001628280-25-020057.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.